Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 90, 54-66
Abstract
No abstract availableKeywords
Funding Information
- University of Colorado Cancer Center (P30CA046934)
- RSNA (RSD1713)
- Cancer League of Colorado
This publication has 20 references indexed in Scilit:
- Cancer Drugs in the United States: Justum Pretium—The Just PriceJournal of Clinical Oncology, 2013
- Strategies for Non-Resectable Head and Neck CancerCurrent Treatment Options in Oncology, 2013
- Statin Use and Reduced Cancer-Related MortalityNew England Journal of Medicine, 2012
- Improved Biochemical Outcomes With Statin Use in Patients With High-Risk Localized Prostate Cancer Treated With RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4Laboratory Investigation, 2009
- Potential antitumor effects of statins (Review)International Journal of Oncology, 2003
- Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated ReceptorsEndocrinology, 2003
- The statins as anticancer agents.2003
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro studyCarcinogenesis, 2001